Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic Drug 180-Day Exclusivity Provisions: Hatch Seeks CBO Score

This article was originally published in The Tan Sheet

Executive Summary

Sen. Orrin Hatch (R-Utah) wants the Congressional Budget Office to help him make the case that 180-day generic drug exclusivity provisions in the Senate and House Medicare bills need revision
Advertisement

Related Content

PTO Tougher On Patent Claims Following Claritin Metabolite Ruling – Attorney
PTO Tougher On Patent Claims Following Claritin Metabolite Ruling – Attorney
Sen. Hatch’s Generic Fix: Limits On 180-Day Marketing Exclusivity Proposed
Sen. Hatch’s Generic Fix: Limits On 180-Day Marketing Exclusivity Proposed
Rx Image Troubles Reflect Flaws In Health Insurance Coverage, Lilly CEO Says
Lilly Outlook For Rx: Political Pressure Will Stay, So Will Double-Digit Growth
Generic Drug 180-Day Exclusivity Reform Proposal Is Cost-Neutral, CBO Says
Generic Rx Delays Could Result From House Medicare Provisions, GPhA Says
Generic Firms Break Camp; FDA Says “First-To-File” Covers Same-Day ANDAs
FDA Generic Rx Reforms Contribute To Medicare Budget Squeeze

Topics

Advertisement
UsernamePublicRestriction

Register

PS095766

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel